Tag Archive for: Medical Affairs

Rosalind Fabunmi, PhD Joins Edwards Lifesciences as Senior Director, Medical Affairs

Life Science Partner is pleased to announce the recruitment of Rosalind Fabunmi, PhD as Senior Director, Medical Affairs with Edwards Lifesciences.

Edwards is committed to focusing on the patient journey from diagnosis to treatment to lifetime outcome, and Fabunmi has a rare combination of skills and experiences which make her highly qualified for her new role. With compelling data on the high individual and societal costs of valvular disease, Edwards is seeking to address the significant unmet need for care.

Rosalind Fabunmi, PhD

Fabunmi will lead Edwards’ evidence development and publication strategy in order to call attention to the prevalence and costs of valvular disease. Importantly, she will also serve as the public face of the company on these issues, engaging key opinion leaders to address the broad lack of awareness.

Fabunmi joins Edwards already possessing subject matter expertise in structural heart disease. Earlier in her career, she served in medical affairs roles for transcatheter aortic valve replacement technologies with Medtronic. Notably, she has also served in medical affairs roles in the pharmaceutical industry, working on heart failure products with Merck and Amylin Pharmaceuticals.

Most recently, Fabunmi served as Senior Director, Medical Affairs with the diabetes company Zafgen. The pharmaceutical industry has blazed the trail on burden of disease data and its use, so Fabunmi’s combination of medical device and pharmaceutical experience in Edwards’ disease space makes her exceptionally qualified for this role. In a career primarily focused on medical affairs, Fabunmi’s experience also encompasses health economics and outcomes research, rendering her almost unique in terms of the skills she brings to Edwards.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

David Mason, MD, Joins MiMedx as Vice President, Medical Affairs and Clinical Programs

Former Senior Vice President, Chief Medical Officer For Given Imaging 

Life Science Partner recruited David Mason, MD to become Vice President, Medical Affairs and Clinical Programs at MiMedx Group, a premier global processor and distributer of human amniotic tissue grafts across multiple therapeutic areas.

Mason joins the MiMedx team from his role at Given Imaging following its acquisition by Covidien earlier this year.

In his new role at MiMedx, Mason will lead the clinical direction and oversight of the company’s product development, research and regulatory compliance. “Mason has the ability and talent to add value to the launch process of small molecules and complex biologics across a range of therapeutic areas,” stated Tom Callaway, MD, Founder and President of Life Science Partner. “In this new role, Mason will oversee Mimedx’ relationship with the FDA and the regulation of these important, tissue-derived products.”

Mason earned his Bachelor of Arts in Chemistry from Williams College in Massachusetts and his MD from Duke University Medical School, North Carolina. Mason is board certified in Internal Medicine and previously specialized in infectious diseases and rheumatology in his private practice.

/0 Comments/by

Life Science Partner Recruits Robert Superko as Vice President of Medical Affairs for Celera

Co-Founder of Berkley HeartLab to Lead Medical Affairs at Celera

Life Science Partner announces the recruitment of Robert Superko, MD, most recently Executive Director of Genomics and Human Health at St. Joseph’s Hospital of Atlanta’s Translational Research Institute, to Celera.

Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries, including a clinical services business, Berkley HeartLab (BHL).  Celera commercializes a wide range of molecular diagnostic products and technologies to provide personalized disease management in cancer and liver diseases.

Dr. Superko is a world leader in the field of metabolic heart disease diagnosis and treatment, and genomics, which is the ability to tailor treatment specifically to a patient based on their genetic makeup.  He has published over 100 manuscripts and 19 textbook chapters and is the author of BEFORE THE HEART ATTACKS, a book written for the lay public explaining advanced aspects of heart disease.

In his role at St. Joseph’s Hospital, Dr. Superko continued his research to identify patients’ genetic susceptibility to heart disease, cancer and other chronic disease states. A co-founder of BHL, Dr. Superko will serve as Vice President of Medical Affairs where he will be the key medical spokesperson for the company’s products and services and the key liaison with physician and research collaborators, including academic medical centers, pharmaceutical companies, and the FDA.

“Superko will bring his deep scientific knowledge, world-renowned reputation, and great passion for understanding the genetic basis of cardiovascular disease to the company,” noted Tom Callaway, President of Life Science Partner.  “There is no better person to prepare Celera’s market for the emerging revolution in personalized disease management.”

Dr. Superko earned his Bachelor of Science degree in Biology from University of California, San Diego, and his Medical degree from the State University of New York, Stony Brook.  He completed his Internship and Fellowship in Internal Medicine at the University of California, Davis.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Hal Mathews, MD to Become VP Medical Affairs for Medtronic Sofamor Danek

To Lead Clinical, Regulatory, Reimbursement Strategy and Physician Relations

Life Science Partner announced today the recruitment of Hallet H. Mathews, MD, to become vice president, medical affairs for Medtronic Sofamor Danek. 

Medtronic Sofamor Danek is the world’s leading orthopaedic company which develops and manufactures products that treat a variety of disorders of the cranium and spine, including traumatically induced conditions, degenerative conditions, deformities and tumors.  Medtronic Sofamor Danek markets its products worldwide and has FY2003 revenue of approximately $1.3 billion.

A leader in the field orthopaedic basic and clinical research, Mathews is a board-certified orthopaedic surgeon.  He is the Founder and President of MidAtlantic Spine Specialists, a multi-disciplinary, multi-specialty group that incorporates Orthopaedic, Neurosurgery and Pain Management & Rehabilitation specialties in Richmond and Williamsburg, Virginia.

“He is a demonstrated clinical leader and general manager – as he now oversees a 10,000 square foot clinic with 45 employees in Richmond and a smaller clinic facility in Williamsburg,” said Tom Callaway, MD, founder and president of Life Science Partner.  “In addition, he has already established strong relationships with the Sofamor Danek clinical investigators worldwide, having participated in and led clinical trials for many of Medtronic’s products.”

In his new role, Mathews will oversee clinical development and regulatory affairs for the Company, with an emphasis on working with business units to identify potential drug or device technologies with strong clinical indications, managing the regulatory strategy globally and overseeing Medtronic Sofamor Danek’s relationships with physicians worldwide.

  Medtronic Sofamor Danek is the leader in the use of biological materials, including the first product using a bioengineered bone morphogenetic protein, INFUSE, which was approved by the Food and Drug Administration (FDA) for use with titanium interbody implants in the lumbar spine.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by